Renal safety and urate-lowering efficacy of febuxostat in gout patients with stage 4-5 chronic kidney disease not yet on dialysis.

Conclusions: Febuxostat demonstrated renal safety and good urate-lowering efficacy in gout patients with stage 4-5 CKD, who are not yet on dialysis.
PMID: 30959584 [PubMed - as supplied by publisher]

Source: The Korean Journal of Internal Medicine - April 7, 2019 Category: Internal Medicine Authors: Kim SH, Lee SY, Kim JM, Son CN Tags: Korean J Intern Med Source Type: research